Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of Urate-Lowering Therapeutics: From the Past to the Future
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Food-derived bioactive peptides with anti-hyperuricemic activity: A comprehensive review
Arshad Mehmood, Asra Iftikhar, Xiumin Chen
Food Chemistry (2024) Vol. 451, pp. 139444-139444
Closed Access | Times Cited: 24
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32
Gout therapeutics and drug delivery
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 24
Large-scale cross-ancestry genome-wide meta-analysis of serum urate
Chamlee Cho, Beomsu Kim, Dan Say Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability
Xiaoyu Shi, Tong Zhao, Shuo Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 5032-5052
Closed Access | Times Cited: 6
Structural Basis for Inhibition of Urate Reabsorption in URAT1
Junping Fan, Wenjun Xie, Han Ke, et al.
JACS Au (2025) Vol. 5, Iss. 3, pp. 1308-1319
Open Access
Biomimetic Integrated Nanozyme for Flare and Recurrence of Gouty Arthritis
Rui Wang, Tongyao Liu, Xinhong Li, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100913-100913
Open Access | Times Cited: 4
Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach
Yedi Herdiana, Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 102-102
Open Access
Molecular mechanisms of Lycii Fructus (Goji berries) against xanthine dehydrogenase in hyperuricemia management: Integrating computational, metabolomic, and experimental approaches
Shuxuan Yang, Qinghong Chen, Yanting You, et al.
Food Research International (2025) Vol. 204, pp. 115926-115926
Closed Access
Ligusticum cycloprolactam ameliorates hyperuricemic nephropathy through inhibition of TLR4/NF-κB signaling
Zhe Chen, Rong Chen, Jiamin Wang, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109864-109864
Open Access
A Bidirectional Mendelian Randomization Study of Tea‐Drinking Habits and Risk of Elevated Serum Uric Acid Levels
Weitian Yan, Xingqiang Wang, Zining Peng, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Open Access
Scaffold Hopping-Based Structural Modification of Tranilast Led to the Identification of HNW005 as a Promising NLRP3 Inflammasome and URAT1 Dual Inhibitor for the Treatment of Gouty Arthritis
Ming Sun, Fengwei Lin, Chenglei Yue, et al.
European Journal of Medicinal Chemistry (2025), pp. 117644-117644
Closed Access
Association between serum uric acid levels and lung function in the NHANES cohort (2007–2012): A cross‐sectional analysis of a diverse American population
Tianlun Kang, Yajing Xi, Siyi Lu, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 2
Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy
Ziang Zhang, Nannan Fu, Qinkai Li, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 666, pp. 115-121
Closed Access | Times Cited: 4
Potentiation of the Uricosuric Effect of Dotinurad byTrans-Inhibition of the Uric Acid Reabsorptive Transporter 1
Fujita Kazuki, Qiunan Zhu, Hiroshi Arakawa, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 11, pp. 1527-1535
Closed Access | Times Cited: 4
Mechanism and use strategy of uric acid-lowering drugs on coronary heart disease
Ruida Cai, F. Li, Yinhao Li, et al.
IJC Heart & Vasculature (2024) Vol. 53, pp. 101434-101434
Open Access | Times Cited: 1
Binding uric acid: a pure chemical solution for the treatment of hyperuricemia
Yunyun Li, Jing Li, Yan Li, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 24165-24174
Open Access | Times Cited: 1
Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents
Zhiqiang Sun, Xuewen Zhang, Zean Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19966-19987
Closed Access | Times Cited: 1
Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial
John K. Botson, K. Obermeyer, Brian LaMoreaux, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis
Seok Hui Kang, Bo‐Yeon Kim, Eun Jung Son, et al.
American Journal of Nephrology (2023) Vol. 54, Iss. 3-4, pp. 117-125
Open Access | Times Cited: 3
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
Yuchen Qu, Yunli Yu, Jie Pan, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152279-152279
Closed Access | Times Cited: 3
Comparative Study of the Lipophilicity of Selected Anti-Androgenic and Blood Uric Acid Lowering Compounds
Dawid Wardecki, Małgorzata Dołowy, Katarzyna Bober, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 166-166
Open Access | Times Cited: 5
The Singapore Experience With Uncontrolled Gout: Unmet Needs in the Management of Patients
Zheng Cong Lee, Anindita Santosa, Andrew Yu Keat Khor, et al.
Cureus (2023)
Open Access | Times Cited: 2
Get on top of gout with a fresh look at treatment options
Caroline Fenton, Connie Kang
Drugs & Therapy Perspectives (2024) Vol. 40, Iss. 3, pp. 115-120
Closed Access
Diabetes and gout: another role for SGLT2 inhibitors?
Clifford J. Bailey
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top